Biphenyl-4-yl acetic acid is a monocarboxylic acid in which one of the alpha-hydrogens is substituted by a biphenyl-4-yl group. 
It is used as a topical medicine to treat muscle inflammation and arthritis. It has a role as a non-steroidal anti-inflammatory drug.

Market Analysis and Insights: Global and China Felbinac (CAS 5728-52-9) Market
This report focuses on global and China Felbinac (CAS 5728-52-9) market.
In 2020, the global Felbinac (CAS 5728-52-9) market size was US$ XX million and it is expected to reach US$ XX million by the end of 2027, with a CAGR of XX% during 2021-2027. In China the Felbinac (CAS 5728-52-9) market size is expected to grow from US$ XX million in 2020 to US$ XX million by 2027, at a CAGR of XX% during the forecast period.

Global Felbinac (CAS 5728-52-9) Scope and Market Size
Felbinac (CAS 5728-52-9) market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Felbinac (CAS 5728-52-9) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.
For China market, this report focuses on the Felbinac (CAS 5728-52-9) market size by players, by Type, and by Application, for the period 2016-2027. The key players include the global and local players which play important roles in China.

Segment by Type
98% Purity Type
97% Purity Type
Others

Segment by Application
Felbinac Gel
Felbinac Tincture
Felbinac Patch
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E

By Company
BLD Pharm
Anward
Aba Chem Scene
TripleBond
LGC Standard
Aurum Pharmatech
FREDA
Hua Luo
Meryer